Asset profile
Durvalumab
Monoclonal antibody
Approvedregulatory verdict
Evidence outlook
Approved: Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Reliable signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
71 competitors in this universe: 10 direct rivals (same mechanism and indication), 1 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Durvalumab: this drug | Approved | Monoclonal antibody | PD-L1 | ||
| Atezolizumab | Approved | Monoclonal antibody | PD-L1 | ||
| Tecentriq Hybreza (atezolizumab And Hyaluronidase-Tqjs) | Approved | Monoclonal antibody | PD-L1 | ||
| Adebrelimab | Phase 3 | Monoclonal antibody | PD-L1 | ||
| CS1001 Monoclonal Antibody | Phase 3 | Monoclonal antibody | PD-L1 | ||
| Envafolimab | Phase 3 | Monoclonal antibody | PD-L1 | ||
| KL-A167 | Phase 3 | Monoclonal antibody | PD-L1 | ||
| PF-08046054 | Phase 3 | Antibody–drug conjugate | PD-L1 | ||
| HLX43 | Phase 2/3 | Antibody–drug conjugate | PD-L1 | ||
| 177Lu-RAD204 | Phase 1 | Radiopharmaceutical | PD-L1 | ||
| BPI-371153 | Phase 1 | Small molecule | PD-L1 | ||
| IBC-Ab002 | Phase 1 | Monoclonal antibody | PD-L1 | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET |
…and 56 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
vs Atezolizumab · Non-Small Cell Lung Cancervs Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) · Non-Small Cell Lung Cancervs CS1001 Monoclonal Antibody · Non-Small Cell Lung Cancervs Envafolimab · Non-Small Cell Lung Cancervs Adebrelimab · Non-Small Cell Lung Cancervs KL-A167 · Non-Small Cell Lung Cancer
4 further head-to-head pairs are tracked; the rosters on each shared mechanism and indication page list every rival in the race.
Upcoming events
(215 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (36)
October 2026 (6)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-23 · NCT06008093 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorRecruiting
Est. primary completion 2026-10-30 · NCT06302426 · CT.gov ↗
What to watch
Phase 2Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2026-10-30 · NCT06060405 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer UnresectableRecruiting
Est. primary completion 2026-10-30 · NCT06591650 · CT.gov ↗
What to watch
Early phase / not applicableBiliary Tract Cancers (BTC)Recruiting
Est. primary completion 2026-10-30 · NCT06611345 · CT.gov ↗
What to watch
Phase 2Bladder CancerActive not recruiting
Est. primary completion 2026-10-31 · NCT03768570 · CT.gov ↗
What to watch
November 2026 (7)
Phase 1/2Esophageal Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaActive not recruiting
Est. primary completion 2026-11 · NCT02962063 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer Extensive StageActive not recruiting
Est. primary completion 2026-11 · NCT05856695 · CT.gov ↗
What to watch
Phase 2Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma, Germinomatous Germ Cell Tumor, Dysgerminoma, Pineal Germ Cell TumorActive not recruiting
Est. primary completion 2026-11 · NCT03158064 · CT.gov ↗
What to watch
Phase 2Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 …Recruiting
Est. primary completion 2026-11-13 · NCT07174570 · CT.gov ↗
What to watch
Phase 1Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma …Recruiting
Est. primary completion 2026-11-30 · NCT06058663 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2026-11-30 · NCT07081633 · CT.gov ↗
What to watch
Phase 2Gastrointestinal Neuroendocrine CarcinomaRecruiting
Est. primary completion 2026-11-30 · NCT06070740 · CT.gov ↗
What to watch
December 2026 (23)
Phase 1Breast CancerActive not recruiting
Est. primary completion 2026-12 · NCT02826434 · CT.gov ↗
What to watch
Phase 1Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal Adenocarcinoma …Recruiting
Est. primary completion 2026-12 · NCT04900818 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2026-12 · NCT05927142 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12 · NCT05000710 · CT.gov ↗
What to watch
Phase 2Breast Neoplasm, Triple Negative Breast Cancer (TNBC), HRDRecruiting
Est. primary completion 2026-12 · NCT03740893 · CT.gov ↗
What to watch
Phase 2Stomach Cancer, AdenocarcinomaRecruiting
Est. primary completion 2026-12 · NCT05620628 · CT.gov ↗
What to watch
Phase 3Oropharyngeal CancerActive not recruiting
Est. primary completion 2026-12 · NCT04116047 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT04585490 · CT.gov ↗
What to watch
Phase 2Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic …Recruiting
Est. primary completion 2026-12-01 · NCT05655949 · CT.gov ↗
What to watch
Phase 4Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-17 · NCT06908070 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerActive not recruiting
Est. primary completion 2026-12-30 · NCT06490107 · CT.gov ↗
What to watch
Phase 2Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast CarcinomaRecruiting
Est. primary completion 2026-12-30 · NCT03606967 · CT.gov ↗
What to watch
Phase 1Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2026-12-31 · NCT05136846 · CT.gov ↗
What to watch
Phase 1Solid Tumor, AdultRecruiting
Est. primary completion 2026-12-31 · NCT03772561 · CT.gov ↗
What to watch
Phase 1Primary Central Nervous System LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04462328 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05844046 · CT.gov ↗
What to watch
Phase 2Pulmonary Large-cell Neuroendocrine CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06418087 · CT.gov ↗
What to watch
Phase 2Ovarian CancerRecruiting
Est. primary completion 2026-12-31 · NCT04918186 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer Limited StageActive not recruiting
Est. primary completion 2026-12-31 · NCT04602533 · CT.gov ↗
What to watch
Phase 2Anal Cancer, Anal Carcinoma, Anal Cancer Stage III, Anal Cancer Stage IIActive not recruiting
Est. primary completion 2026-12-31 · NCT04230759 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06698250 · CT.gov ↗
What to watch
Phase 2Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2026-12-31 · NCT03937830 · CT.gov ↗
What to watch
Phase 3CancerEnrolling by invitation
Est. primary completion 2026-12-31 · NCT05303532 · CT.gov ↗
What to watch
2027 (80)
January 2027 (10)
Phase 1Solid Tumor, Adult, Malignant Solid Tumor, Stomach Adenocarcinoma, Esophageal AdenocarcinomaRecruiting
Est. primary completion 2027-01 · NCT06824363 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-01 · NCT05206812 · CT.gov ↗
What to watch
Phase 2Extrahepatic Cholangiocarcinoma, Unresectable Perihilar or Ductal CCARecruiting
Est. primary completion 2027-01 · NCT06440993 · CT.gov ↗
What to watch
Phase 2Extensive Stage Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-01 · NCT04699838 · CT.gov ↗
What to watch
Phase 2Mismatch Repair Proficient Colorectal Cancer, Pancreatic Adenocarcinoma, LeiomyosarcomaActive not recruiting
Est. primary completion 2027-01-01 · NCT03851614 · CT.gov ↗
What to watch
Phase 2Biliary Tract Neoplasms ImmunotherapyRecruiting
Est. primary completion 2027-01-01 · NCT07679399 · CT.gov ↗
What to watch
Phase 2Esophagus AdenocarcinomaActive not recruiting
Est. primary completion 2027-01-01 · NCT05713838 · CT.gov ↗
What to watch
Phase 2Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8Not yet recruiting
Est. primary completion 2027-01-01 · NCT07332351 · CT.gov ↗
What to watch
Phase 2Lung CancerActive not recruiting
Est. primary completion 2027-01-18 · NCT05374603 · CT.gov ↗
What to watch
Phase 2Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8, Stage IVA Bladder Cancer AJCC v8, Stage IVB Bladder Cancer AJCC v8Active not recruiting
Est. primary completion 2027-01-31 · NCT03601455 · CT.gov ↗
What to watch
February 2027 (6)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT06463665 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-02 · NCT04716946 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT04499053 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT05696782 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2027-02-22 · NCT05388006 · CT.gov ↗
What to watch
Phase 1BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma …Active not recruiting
Est. primary completion 2027-02-23 · NCT04605731 · CT.gov ↗
What to watch
March 2027 (5)
Phase 2Extensive-stage Small-cell Lung CancerRecruiting
Est. primary completion 2027-03 · NCT06223711 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-03-01 · NCT03983954 · CT.gov ↗
What to watch
Phase 1/2Bladder CancerRecruiting
Est. primary completion 2027-03-30 · NCT04106115 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-03-30 · NCT05422690 · CT.gov ↗
What to watch
Phase 1Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin NeoplasmActive not recruiting
Est. primary completion 2027-03-31 · NCT04387084 · CT.gov ↗
What to watch
April 2027 (1)
Phase 2Advanced Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-04 · NCT07175441 · CT.gov ↗
What to watch
May 2027 (7)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-05 · NCT03694236 · CT.gov ↗
What to watch
Phase 2Combined Hepatocellular and CholangiocarcinomaNot yet recruiting
Est. primary completion 2027-05 · NCT06855225 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Resectable Colorectal CarcinomaRecruiting
Est. primary completion 2027-05 · NCT05845450 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-05 · NCT06375915 · CT.gov ↗
What to watch
Phase 1/2Metastatic Biliary Tract CancerRecruiting
Est. primary completion 2027-05-01 · NCT06548412 · CT.gov ↗
What to watch
Phase 2Gastric CancerActive not recruiting
Est. primary completion 2027-05-04 · NCT04379596 · CT.gov ↗
What to watch
Phase 1/2Lung CancerRecruiting
Est. primary completion 2027-05-30 · NCT05886439 · CT.gov ↗
What to watch
June 2027 (12)
Phase 1Gastroesophageal AdenocarcinomaRecruiting
Est. primary completion 2027-06 · NCT05733689 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT05742607 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-06 · NCT05063565 · CT.gov ↗
What to watch
Phase 1Advanced Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-06-01 · NCT06470256 · CT.gov ↗
What to watch
Phase 1Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Cholangiocarcinoma, Locally Advanced Pancreatic Adenocarcinoma …Recruiting
Est. primary completion 2027-06-01 · NCT07619313 · CT.gov ↗
What to watch
Phase 2Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid NeoplasmRecruiting
Est. primary completion 2027-06-01 · NCT03907475 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular CarcinomaRecruiting
Est. primary completion 2027-06-25 · NCT06796114 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06-30 · NCT04686305 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerNot yet recruiting
Est. primary completion 2027-06-30 · NCT06502080 · CT.gov ↗
What to watch
Phase 2Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma, Recurrent Angiosarcoma …Active not recruiting
Est. primary completion 2027-06-30 · NCT04668300 · CT.gov ↗
What to watch
Phase 2Lung Adenocarcinoma, Lung Large Cell Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-06-30 · NCT05198830 · CT.gov ↗
What to watch
Phase 3Esophageal Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-06-30 · NCT04550260 · CT.gov ↗
What to watch
July 2027 (7)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-07 · NCT03999710 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma, FGFR2 Gene Rearrangement, FGFR2 Gene MutationRecruiting
Est. primary completion 2027-07 · NCT06728410 · CT.gov ↗
What to watch
Phase 3Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung CancerActive not recruiting
Est. primary completion 2027-07-05 · NCT06211036 · CT.gov ↗
What to watch
Phase 3Breast CancerRecruiting
Est. primary completion 2027-07-28 · NCT06103864 · CT.gov ↗
What to watch
Phase 2Esophageal CancerRecruiting
Est. primary completion 2027-07-31 · NCT06290505 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma Non-resectable, HCCActive not recruiting
Est. primary completion 2027-07-31 · NCT04522544 · CT.gov ↗
What to watch
Phase 2Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8Recruiting
Est. primary completion 2027-07-31 · NCT06263153 · CT.gov ↗
What to watch
August 2027 (4)
Phase 2Locally Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8 …Not yet recruiting
Est. primary completion 2027-08-01 · NCT07511504 · CT.gov ↗
What to watch
Phase 2ImmunotherapyActive not recruiting
Est. primary completion 2027-08-10 · NCT04169841 · CT.gov ↗
What to watch
Phase 1Solid TumoursRecruiting
Est. primary completion 2027-08-30 · NCT07391670 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-08-31 · NCT04465968 · CT.gov ↗
What to watch
September 2027 (6)
Phase 2Cancer, Tumors, Neoplasm, NeoplasiaRecruiting
Est. primary completion 2027-09 · NCT02925234 · CT.gov ↗
What to watch
Phase 3Breast CancerActive not recruiting
Est. primary completion 2027-09-20 · NCT05629585 · CT.gov ↗
What to watch
Phase 2HCC - Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-09-27 · NCT06045975 · CT.gov ↗
What to watch
Phase 2Extensive-stage Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT04397003 · CT.gov ↗
What to watch
Phase 2Extensive-Stage Small-Cell Lung CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT05796089 · CT.gov ↗
What to watch
Phase 2/3Renal Pelvis and Ureter Urothelial CarcinomaRecruiting
Est. primary completion 2027-09-30 · NCT04628767 · CT.gov ↗
What to watch
October 2027 (6)
Phase 2Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung CancerRecruiting
Est. primary completion 2027-10-01 · NCT05068232 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Cirrhosis, LiverRecruiting
Est. primary completion 2027-10-01 · NCT06526104 · CT.gov ↗
What to watch
Early phase / not applicableNon-Small Cell Lung CancerRecruiting
Est. primary completion 2027-10-01 · NCT06484491 · CT.gov ↗
What to watch
Phase 3Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-10-12 · NCT07027436 · CT.gov ↗
What to watch
Phase 1/2Colorectal Neoplasms, Breast NeoplasmsActive not recruiting
Est. primary completion 2027-10-30 · NCT02484404 · CT.gov ↗
What to watch
Phase 2Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-10-30 · NCT04940286 · CT.gov ↗
What to watch
November 2027 (1)
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-11-01 · NCT05687266 · CT.gov ↗
What to watch
December 2027 (15)
Phase 1Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-12 · NCT06710223 · CT.gov ↗
What to watch
Phase 1Biliary Tract Cancer, CholangiocarcinomaRecruiting
Est. primary completion 2027-12 · NCT06546969 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast Cancer MetastaticRecruiting
Est. primary completion 2027-12 · NCT05582538 · CT.gov ↗
What to watch
Phase 2Extensive Stage Lung Small Cell CancerNot yet recruiting
Est. primary completion 2027-12 · NCT07172412 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer, Lung CancerActive not recruiting
Est. primary completion 2027-12 · NCT04472949 · CT.gov ↗
What to watch
Phase 2Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer, HER2 Low Breast Adenocarcinoma, Breast CancerRecruiting
Est. primary completion 2027-12-01 · NCT05795101 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Biliary Tract CancerRecruiting
Est. primary completion 2027-12-01 · NCT05733598 · CT.gov ↗
What to watch
Phase 2Non-muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial CarcinomaRecruiting
Est. primary completion 2027-12-22 · NCT06503614 · CT.gov ↗
What to watch
Phase 1Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma …Active not recruiting
Est. primary completion 2027-12-31 · NCT02812420 · CT.gov ↗
What to watch
Phase 1/2Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7 …Active not recruiting
Est. primary completion 2027-12-31 · NCT02726997 · CT.gov ↗
What to watch
Phase 1/2Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-12-31 · NCT04728230 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Lung CancerRecruiting
Est. primary completion 2027-12-31 · NCT05632809 · CT.gov ↗
What to watch
Phase 2Locally Advanced Ampulla of Vater Carcinoma, Locally Advanced Biliary Tract Carcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma …Recruiting
Est. primary completion 2027-12-31 · NCT07780838 · CT.gov ↗
What to watch
Early phase / not applicableExtrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT07235007 · CT.gov ↗
What to watch
2028 (48)
January 2028 (6)
Phase 2Malignant Solid NeoplasmsRecruiting
Est. primary completion 2028-01 · NCT02029001 · CT.gov ↗
What to watch
Phase 2Epithelial Ovarian CancerRecruiting
Est. primary completion 2028-01 · NCT04644289 · CT.gov ↗
What to watch
Phase 2Adenocarcinoma of Lung, Lung CancerRecruiting
Est. primary completion 2028-01 · NCT04105270 · CT.gov ↗
What to watch
Phase 2Extrapulmonary Small Cell CarcinomaRecruiting
Est. primary completion 2028-01-01 · NCT06464068 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-01-31 · NCT06880523 · CT.gov ↗
What to watch
Phase 2Extensive-stage Small-cell Lung CancerRecruiting
Est. primary completion 2028-01-31 · NCT07459634 · CT.gov ↗
What to watch
February 2028 (3)
Phase 2Triple Negative Breast CancerRecruiting
Est. primary completion 2028-02 · NCT06954480 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Liver CancerNot yet recruiting
Est. primary completion 2028-02 · NCT07226063 · CT.gov ↗
What to watch
Phase 2Small Cell Lung CarcinomaActive not recruiting
Est. primary completion 2028-02-24 · NCT05617963 · CT.gov ↗
What to watch
March 2028 (4)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-03-01 · NCT07653438 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-03-31 · NCT06911255 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaActive not recruiting
Est. primary completion 2028-03-31 · NCT05034887 · CT.gov ↗
What to watch
Phase 2Clear Cell Renal Cell Carcinoma, Locally Advanced Pancreatic Cancer, Locally Advanced Malignant Solid Neoplasm …Active not recruiting
Est. primary completion 2028-03-31 · NCT03682289 · CT.gov ↗
What to watch
April 2028 (2)
May 2028 (2)
June 2028 (3)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-06 · NCT06680050 · CT.gov ↗
What to watch
Phase 1/2Gastric Cancer, Esophageal Adenocarcinoma, Hepatocellular Carcinoma, Colorectal CancerRecruiting
Est. primary completion 2028-06-30 · NCT03539822 · CT.gov ↗
What to watch
Phase 3Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2028-06-30 · NCT06732401 · CT.gov ↗
What to watch
July 2028 (3)
Phase 4Oncology, Infusion ReactionRecruiting
Est. primary completion 2028-07 · NCT06031233 · CT.gov ↗
What to watch
Phase 2CholangiocarcinomaRecruiting
Est. primary completion 2028-07-01 · NCT07673341 · CT.gov ↗
What to watch
Phase 2Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 …Recruiting
Est. primary completion 2028-07-31 · NCT04430452 · CT.gov ↗
What to watch
August 2028 (1)
Phase 2Urothelial Carcinoma, Bladder CancerActive not recruiting
Est. primary completion 2028-08-31 · NCT05137262 · CT.gov ↗
What to watch
September 2028 (3)
Phase 2Resectable Gasrtic CancerNot yet recruiting
Est. primary completion 2028-09 · NCT07757191 · CT.gov ↗
What to watch
Phase 2Large Cell Neuroendocrine Carcinoma of the LungRecruiting
Est. primary completion 2028-09 · NCT06393816 · CT.gov ↗
What to watch
Phase 1/2Fibrolamellar Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-09-01 · NCT06027086 · CT.gov ↗
What to watch
October 2028 (5)
Phase 2Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2028-10-08 · NCT07288034 · CT.gov ↗
What to watch
Phase 2Stomach NeoplasmsRecruiting
Est. primary completion 2028-10-30 · NCT06630130 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-10-31 · NCT03833154 · CT.gov ↗
What to watch
Phase 3Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine, Doxorubicin, Cisplatin, GemcitabineRecruiting
Est. primary completion 2028-10-31 · NCT06960577 · CT.gov ↗
What to watch
November 2028 (5)
Phase 2Advanced Biliary Tract CarcinomaRecruiting
Est. primary completion 2028-11 · NCT07036380 · CT.gov ↗
What to watch
Phase 2Advanced Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2028-11-19 · NCT06858735 · CT.gov ↗
What to watch
Phase 3Breast CancerActive not recruiting
Est. primary completion 2028-11-20 · NCT06112379 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-11-30 · NCT01993810 · CT.gov ↗
What to watch
Phase 3Advanced or Recurrent Endometrial CancerActive not recruiting
Est. primary completion 2028-11-30 · NCT06746116 · CT.gov ↗
What to watch
December 2028 (11)
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-12 · NCT04597671 · CT.gov ↗
What to watch
Phase 3Biliary Tract CancerRecruiting
Est. primary completion 2028-12-01 · NCT06282575 · CT.gov ↗
What to watch
Phase 3Extensive-stage Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-16 · NCT06719336 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12-30 · NCT06492421 · CT.gov ↗
What to watch
Phase 2Hepatic Cancer, SurgeryRecruiting
Est. primary completion 2028-12-30 · NCT06492408 · CT.gov ↗
What to watch
Phase 2Lung Cancer, Inoperable DiseaseRecruiting
Est. primary completion 2028-12-30 · NCT06483347 · CT.gov ↗
What to watch
Phase 1/2Urothelial Carcinoma, Bladder CancerActive not recruiting
Est. primary completion 2028-12-31 · NCT03317158 · CT.gov ↗
What to watch
Phase 2Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype, Lung Small Cell Carcinoma, I Subtype …Recruiting
Est. primary completion 2028-12-31 · NCT06769126 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12-31 · NCT06667908 · CT.gov ↗
What to watch
Phase 2HCCActive not recruiting
Est. primary completion 2028-12-31 · NCT04988945 · CT.gov ↗
What to watch
Phase 3Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2028-12-31 · NCT04092283 · CT.gov ↗
What to watch
2029 (24)
January 2029 (1)
Phase 3Small-cell Lung Cancer, Extensive Stage Small-cell Lung CancerActive not recruiting
Est. primary completion 2029-01-04 · NCT07005128 · CT.gov ↗
What to watch
February 2029 (2)
March 2029 (2)
Phase 1Biliary Tract CancersRecruiting
Est. primary completion 2029-03 · NCT06564623 · CT.gov ↗
What to watch
Phase 3Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8Recruiting
Est. primary completion 2029-03-10 · NCT07166406 · CT.gov ↗
What to watch
April 2029 (2)
May 2029 (2)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-05 · NCT06890598 · CT.gov ↗
What to watch
Phase 2Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 …Recruiting
Est. primary completion 2029-05-25 · NCT06078709 · CT.gov ↗
What to watch
June 2029 (1)
Phase 3Small Cell Lung CarcinomaActive not recruiting
Est. primary completion 2029-06-30 · NCT06992609 · CT.gov ↗
What to watch
July 2029 (4)
Phase 1/2Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3Recruiting
Est. primary completion 2029-07 · NCT07174583 · CT.gov ↗
What to watch
Phase 2/3Gall Bladder CancerRecruiting
Est. primary completion 2029-07-21 · NCT06214572 · CT.gov ↗
What to watch
Phase 1/2Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2029-07-25 · NCT06287775 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer Limited StageRecruiting
Est. primary completion 2029-07-31 · NCT07055581 · CT.gov ↗
What to watch
August 2029 (2)
September 2029 (3)
Phase 1/2Biliary Tract Neoplasms, Advanced Cancer, ImmunotherapyNot yet recruiting
Est. primary completion 2029-09 · NCT07269158 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular CarcinomaRecruiting
Est. primary completion 2029-09-14 · NCT06904170 · CT.gov ↗
What to watch
Phase 2Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2029-09-30 · NCT04892953 · CT.gov ↗
What to watch
October 2029 (3)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-10 · NCT06284317 · CT.gov ↗
What to watch
Phase 1/2Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer, Ovary Cancer, Head and Neck Cancer, Breast Cancer, Gastric Cancer …Recruiting
Est. primary completion 2029-10-30 · NCT05187338 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer, Limited Stage Small-Cell Lung CancerRecruiting
Est. primary completion 2029-10-31 · NCT05903092 · CT.gov ↗
What to watch
2030 (17)
January 2030 (2)
February 2030 (1)
Phase 2Esophagogastric AdenocarcinomaNot yet recruiting
Est. primary completion 2030-02-01 · NCT07507968 · CT.gov ↗
What to watch
April 2030 (3)
Phase 2Hepato Cellular CarcinomaRecruiting
Est. primary completion 2030-04-01 · NCT07489976 · CT.gov ↗
What to watch
Phase 1/2Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides …Recruiting
Est. primary completion 2030-04-14 · NCT03011814 · CT.gov ↗
What to watch
May 2030 (5)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-05-28 · NCT05061550 · CT.gov ↗
What to watch
Phase 1Extensive Stage Small Cell Lung CancerActive not recruiting
Est. primary completion 2030-05-30 · NCT05361395 · CT.gov ↗
What to watch
Phase 1/2Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8 …Recruiting
Est. primary completion 2030-05-31 · NCT03942328 · CT.gov ↗
What to watch
Phase 2HCC - Hepatocellular Carcinoma, Tremelimumab, Durvalumab, RadiotherapyRecruiting
Est. primary completion 2030-05-31 · NCT06999707 · CT.gov ↗
What to watch
Phase 2HCC - Hepatocellular Carcinoma, Durvalumab, Tremelimumab, Proton RadiotherapyRecruiting
Est. primary completion 2030-05-31 · NCT06999694 · CT.gov ↗
What to watch
June 2030 (2)
November 2030 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2030-11 · NCT07759492 · CT.gov ↗
What to watch
December 2030 (3)
Phase 2Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma, TNBC - Triple-Negative Breast Cancer, HER2-positive Breast Cancer …Recruiting
Est. primary completion 2030-12 · NCT01042379 · CT.gov ↗
What to watch
Phase 2Resectable Intrahepatic CholangiocarcinomaNot yet recruiting
Est. primary completion 2030-12-10 · NCT07639528 · CT.gov ↗
What to watch
Phase 2Liver Cancer, AntibodyRecruiting
Est. primary completion 2030-12-30 · NCT06482801 · CT.gov ↗
What to watch
2031 (4)
June 2031 (1)
Phase 1Small Cell Lung CancerActive not recruiting
Est. primary completion 2031-06-23 · NCT06898957 · CT.gov ↗
What to watch
October 2031 (1)
Phase 3Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8Recruiting
Est. primary completion 2031-10-15 · NCT05624996 · CT.gov ↗
What to watch
November 2031 (1)
Phase 2MPNST, NF1, SarcomaRecruiting
Est. primary completion 2031-11-15 · NCT05253131 · CT.gov ↗
What to watch
December 2031 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2031-12-30 · NCT07247786 · CT.gov ↗
What to watch
2032 (4)
May 2032 (1)
Phase 3Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma …Recruiting
Est. primary completion 2032-05-31 · NCT06058377 · CT.gov ↗
What to watch
July 2032 (1)
Phase 2Colorectal Cancer, Endometrial CancerRecruiting
Est. primary completion 2032-07-01 · NCT06680739 · CT.gov ↗
What to watch
August 2032 (1)
Phase 2Intrahepatic CholangiocarcinomaNot yet recruiting
Est. primary completion 2032-08 · NCT07766187 · CT.gov ↗
What to watch
December 2032 (1)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2032-12-15 · NCT07554339 · CT.gov ↗
What to watch
2037 (1)
November 2037 (1)
Phase 3Limited Stage Small-Cell Lung CancerNot yet recruiting
Est. primary completion 2037-11 · NCT07637513 · CT.gov ↗
What to watch
2039 (1)
July 2039 (1)
Phase 3Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Recruiting
Est. primary completion 2039-07-15 · NCT06498635 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.